Follow-up study of infants recruited to the randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants—study protocol for the AZTEC-FU study

Follow-up study of infants recruited to the randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants—study protocol for the AZTEC-FU study

Abstract Background Preterm birth, especially at less than 30 weeks’ gestation, is significantly associated with respiratory, neurodevelopmental and growth abnormalities. The AZTEC study has recruited 799 infants born at < 30 weeks’ gestation to determine if a ten-day intravenous treatment with a...

Full description

Bibliographic Details
Main Authors: Sarah J. Kotecha, Christopher W. Course, Kathryn E. Jones, W. John Watkins, Janet Berrington, David Gillespie, Sailesh Kotecha
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Trials
Subjects:
Neonates
Preterm
Azithromycin
Neurodevelopment
Chronic lung disease
Bronchopulmonary dysplasia
Online Access:https://doi.org/10.1186/s13063-022-06730-x

Similar Items

Similar Items